Quality of life assessment in clinical cancer research
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In attempting to reach a more comprehensive evaluation of treatment efficacy beyond the objective aspects of achieving optimal survival, maximal tumour response and minimal toxicity, additional end-points in cancer clinical trials were introduced that take into account the subjective response of the patients to their illness and its treatment.
Abstract
Classical end-points in clinical therapeutic trials in oncology are usually defined by total, recurrence-free or systemic disease-free survival.Primarily, these allow an adequate de- scription of the biological course of the disease.In current
